Kemoterapi alan akciğer kanserli hastalarda semptom kümelerinin belirlenmesi

Yıl 2022, , 17 - 26, 23.04.2022

Özlem Uğur , Hatice Mert , Ezgi Karadağ , Haydar Soydaner Karakuş , Tugba Yavuzşen İlhan Öztop , Canan Demir Barutcu

https://doi.org/10.30569/adiyamansaglik.958170

Öz

Amaç: Amaç kemoterapi alan akciğer kanserli hastaların yaşadığı semptomların ve semptom kümelerinin belirlenmesidir.
Gereç ve Yöntem: Tanımlayıcı ve kesitsel bir çalışmadır. Çalışmada "Hasta Sunum Formu", "ECOG Performans Ölçeği", "Memorial Semptom Değerlendirme Ölçeği" kullanılmıştır. Veriler Eylül 2016 ile Haziran 2017 tarihleri arasında toplanmıştır. Araştırmanın örneklemini seçim kriterlerini karşılayan 100 hasta oluşturmuştur.
Bulgular: Hastaların yaşadıkları semptomların yaygınlığı incelendiğinde en sık görülen semptomların enerji eksikliği (%82), iştahsızlık (%71), tad değişikliği (%62), kaygı ve huzursuzluk (%69) olduğu saptanmıştır. En sık görülen semptomlar ise halsizlik (%8), iştahsızlık (%14), kaygı (%20) ve üzgün hissetmedir (%28).
Sonuç: Sıklığı ve şiddet dereceleri incelendiğinde; semptomlar gastrointestinal sistem kümesi, psikoloji kümesi, solunum kümesi, nöroloji kümesi ve cilt değişiklikleri kümesi olmak üzere beş gruba ayrılmıştır. Akciğer kanserli hastaların semptomları birbirleriyle etkileşim halindedir ve uygun müdahalelerle tedavi edilmelidir. Ayrıca sağlık profesyonellerinin semptom yönetimi konusunda farkındalıkları artırılmalıdır.

Anahtar Kelimeler

Kemoterapi, Akciğer kanseri, Semptom kümeleri

Destekleyen Kurum

Yok

Proje Numarası

Yok

Teşekkür

Çalışmaya katılım gösteren tüm hastalarımıza teşekkür ediyorum. Ayrıca iyi bir çalışma süreci gösterdiğimiz ekip üyelerine de teşekkür ediyorum.

Symptom clusters in patients with lung cancer patients receiving chemotherapy

Öz

Aim: The aim was to identify symptoms experienced by patients with lung cancer who had received chemotherapy and to determine the symptom clusters.
Materials and Methods: This was a descriptive and cross-sectional study. A Patient Presentation Form, the ECOG Performance Scale, and the Memorial Symptom Assessment Scale were used. The data were collected between September 2016 and June 2017. The sample of the study consisted of 100 patients who met the selection criteria.
Results: When the prevalence of the symptoms experienced by the patients was examined, the most common complaints were lack of energy (82%), loss of appetite (71%), change in taste of food (62%), anxiety and feeling irritable (69%). The most common symptoms were weakness (8%), loss of appetite (14%), anxiety (20%) and feeling sad (28%).
Conclusion: When the occurrence and severity ratings were examined, the symptoms could be placed into five groups: the gastrointestinal system cluster, the psychology cluster, the respiratory cluster, the neurology cluster, and the cluster of skin changes. The symptoms of lung cancer patients interact with each other and should be managed with appropriate interventions. Moreover, health professionals’ awareness of symptom management should be improved.

Anahtar Kelimeler

Chemotherapy, Lung cancer, Symptom clusters

Proje Numarası

Yok

Kaynakça

• Grossman M, Agulnik J, Batis G. The peter brojda lung cancer center: model of integrative practice. Curr Oncol. 2012; 19(3):145-159. doi:10.3747/co.19.929
• Siegel RL, Miller KM, Jemal A. Cancer Statistics. CACancerJ Clin., 2018; 68(1):7-30. doi:10.3322/caac.21551
• Carnio S, Di Stefano RF, Novello S. Fatigue in lung cancer patients: Symptom burden and management of challenges. Lung Cancer 2016; 9(7):73-82. doi: 10.2147/LCTT.S85334
• Cancer Today-Global Cancer Observatory. (GLOBACAN). https://gco.iarc.fr/today/onlineanalysis/Access date: 05.06.2021
• Akın S, Aslan E. Symptom group concept and preference. Istanbul University Florence Nightingale J of Nurs School. 2007;15 (60),200-205. https://dergipark.org.tr/tr/pub/fnjn/issue/9025/112525
• Given B. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Research. 2001;50(4):222-32.
• Dodd MJ, Mıaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28(3):465–470.
• Dhillon HM, Bell ML, Ploeg VD, Turner DJ, Kabourakis M, Spencer L, et al. Impact of physical activity on fatique and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann of Oncol,.2017; 28(8):1889- 1897. doi:10.1093/annonc/mdx205
• Beck SL, Schwartz A. Unrelieved pain contributes of fatigue and insomnia. Oncol Nurs Forum. 2000;27, 350.
• Kim HJ, Barsevick AM, Tulman L, McDermott PA. Treatment related symptom clusters in breast cancer: Asecondary analysis. J Pain Symptom Manage. 2008;36(5):468-79. doi: 10.1016/j.jpainsymman.2007.11.011
• Ozdamar K. SPSS applied basic statistics. Ankara (Turkey): Seçkin press. 2018, Turkish.
• Yildirim Y, Tokem Y, Bozkurt N, Fadiloğlu Ç, Uyar M, Uslu R. Reliability and validity of the Turkish version of the Memorial Symptom Assessment Scale in cancer patients. Asian Pacific Journal of Cancer Preven. 2011;(12):3389-3396.
• Atay, S. Determination of symptom frequency and symptom clusters in children with cancer treatment. (Doctoral Thesis) Dokuz Eylül University Faculty of Medicine, Department of Child Health and Disease Nursing. 2008, Turkish.
• Oken MM, Creech RH, Tormey DC, Horton J, Davis ET, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;(5):649- 655.
• Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander Klar H, Kiyasu E. et al. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevelance, characteristics and distress. Eur J Cancer. 1994; 30(9): 326-36. doi: 10.1016/0959-8049(94) 90182-1.
• Akın S, Durna Z. Lung cancer and care, chronic diseases and care. İstanbul (Turkey): Nobel Medical Bookstores.2012; (1):161-176, Turkish.
• Can G, Aydıner A. Palliative care in lung cancer. Nobel Medical Bookstores İstanbul (Turkey). 2015;43-46, Turkish.
• Nowicki, A, Piekarska, J, Farbicka, P. The assessment of cancer-related fatigue syndrome in patients with lung cancer during palliative chemotherapy. Adv Respir Med. 2017, 85,69–76. doi: 10.5603/ARM.2017.0013.
• Akin S, Guner KC. Determinants of fatigue, self-efficacy, and quality of life of cancer patients during chemotherapy. J of Nurs Sci. 2017;3(4), Corpus ID: 17-26. 11902740
• Nogueira IC, Araújo AS, Morano MT, Cavalcante GA, de Bruin FP, Paddison SJ et al. Assessment of fatigue using the identity consequence fatigue scale in patients with lung cancer. J Bras Pneumol. 2017;43(3):169-175. doi: 10.1590/S1806-37562016000000033.
• Sanja Š, Rade M, Mira V, Momir Š. Quality of life of patients with non- obstructive lung cancer. Militarism Revie. 2017; 77 (7):625-632. doi:10.2147/OTT.S100685
• Atieh G, Hamidreza H. The Relationship between fatigue and psychological symptoms in patients with gastrointestinal cancer. Caspian J Neurol Sci., 2018; 2(5),29-35.
• Hamada T, Komatsu H, Rosenzweig MQ, Chohnabayashi N, Nishumuro N, Oizumo N, et al. Impact of symptom clusters on quality-of-life outcomes in patients from Japan with advanced nonsmall cell lung cancers. Asia Pac J Oncol Nurs, 2016;3(4): 370-381. doi: 10.4103/2347-5625.196489
• Khamboon T, Pongthavornkamol K, Olson K, Wattanakitkrileart D, Viwatwongkasem C, Lausoontornsiri W. Symptom experiences and symptom cluster across dimensions in this with advanced lung cancer. Pac Rim Int Nurs Res. 2015; 19:330-44. doi: 10.1186/s13054-016-1208-6.
• Wang D, Fu J. Symptom clusters and quality of life in China patients with lung cancer undergoing chemotherapy. Afr Health Sci. 2014;14(1): 49-55.
• Sullivan WC, Leutwyler H, Dunn BL, Cooper B, Paul MS, Coney PY et al. Differences in symptom clusters identified using symptom occurence rates versus severity ratings in patients with breast cancer undergoing chemotherapy. Eur J of Oncol Nurs. 2017; 28,122- 132. doı:10.1016/j.ejon.2017.04.001
• Süren M, Doğru S, Önder Y, Çeltek YN, Okan İ, Çıtıl R, et al. Investigation of symptom clusters in end stage cancer patients. Pain. 2015;27 (1):12-17.
• Dhillon HM, van der Ploeg HP, Bell ML, Boyer M, Clarke S, Vardy J. The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol. BMC Cancer, 2012; 5(12):57. doi: 10.1186/1471-2407-12-572.
• Kim HJ, Mcguire DB, Tulman L, Barsevick AM. Symptom clusters concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005; 28(4): 270-282. doi: 10.1097/00002820-200507000-00005.
• Soylu C. Cognitive behavioral therapy in cancer patients. Current Approach in Psychiat. 2014; 6(3):257-270. doi: 10.5455/cap.20131231033203
• Süren M, Okan İ, Kaya Z, Karaman S, Arıci S, Çömlekçi M, et al. İnitial experience with delivery of palliative care to terminal cancer patients. Turk J MedSci. 2016; 46(2): 388-92. doi:10.3906/sag-1410-97
• Sezgin GM, Bektaş H. Symptom clustering and its effect on functional status in lymphoma patients. Florence Nıghtingale J Nurs 2020; 28(2):143-154. doi:10.5152/FNJN.2020.19107
• Tuna A, Bektaş M, Tuna A, Çelik GO, İlçe A. Clusters of symptoms sign in patients with glial brain tümör. Anatol J Clin Investig. 2014;8(2):62-67.
• Erdem E. Symptom clustering and Parenteral Care Burden Review in Children with Leukomia. Gazi Üniversity Institur of Health Sciences. 2016; Master Thesis, Ankara.
• Russel J, Wong LM, Mackin L. Paul MS, Cooper AB, Hammer M, et al. Stability of Symptom Clusters in Patients with Lung Cancer Receiving Chemotherapy. J of Pain and Symptom Manage. 2019; 57(5):909-922. doi: 10.1016/j.jpainsymman.2019.02.002.
• Tolotti A, Bonetti L, Pedrazzani C, Bianchi M, Moser L, Pagnucci N, et al. Nursing management of fatigue in cancer patients and suggestions for clinical practice: A mixed methods study. BMC Nur. 2021; 20(82):1-14. doi:10.1186/s12912-021-00699-9